Resolve Therapeutics Partnering

Partner needed to conduct clinical development and commercialization

Resolve is looking for a partner for RSLV-132 to conduct late stage clinical development and commercialization. We are interested to speak with pharmaceutical companies that have the infrastructure, experience, and commitment to bring this potentially transformative new medicine to patients. Please contact James Posada, CEO at to learn more about our company and discuss the opportunities that lay ahead of us.